Literature DB >> 1411898

The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system.

N Romani1, G Schuler.   

Abstract

Dendritic cells form a system of antigen-presenting cells that is widely distributed in the body. They constitute trace populations in lymphoid and non-lymphoid tissues and in the circulation. They are characterized by their typical dendritic and "veiled" morphology, by their constitutive expression of high levels of major histocompatibility complex class II molecules on their surface, and by their outstanding capacity to initiate primary immune responses. Dendritic cells occur in two states of differentiation. In the immature state they are highly specialized for processing foreign protein antigens; in the mature state they efficiently stimulate resting antigen-specific T cells. Dendritic cells can migrate from the non-lymphoid tissues, where they reside in the immature state, via the afferent lymphatics or the blood to the T cell-dependent areas of the lymphoid organs (lymph nodes, spleen). There, they appear as mature dendritic cells. Therefore, dendritic cells are ideally suited to mediate important aspects of immunogenicity: they can acquire antigens in the tissues and process them in an immunogenic form; they can carry the immunogen to the lymphoid organs; and they can find and efficiently activate antigen-specific T cell clones and thus generate an immune response. Studies of epidermal Langerhans cells have greatly helped in establishing this concept. They can be investigated freshly isolated from the epidermis where they represent immature (tissue) dendritic cells. After 2-3 days in culture they develop into mature dendritic cells. The mechanisms of dendritic cell maturation, which can be studied best using epidermal Langerhans cells, and the specific functions of Langerhans cells in immunogenicity are discussed.

Mesh:

Year:  1992        PMID: 1411898     DOI: 10.1007/bf00200527

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  66 in total

1.  Human tonsillar dendritic cell-induced T cell responses: analysis of molecular mechanisms using monoclonal antibodies.

Authors:  P D King; D R Katz
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

2.  Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells.

Authors:  J W Young; R M Steinman
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

3.  The minimal number of class II MHC-antigen complexes needed for T cell activation.

Authors:  S Demotz; H M Grey; A Sette
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

4.  Human epidermal Langerhans cells undergo profound morphologic and phenotypical changes during in vitro culture.

Authors:  M B Teunissen; J Wormmeester; S R Krieg; P J Peters; I M Vogels; M L Kapsenberg; J D Bos
Journal:  J Invest Dermatol       Date:  1990-02       Impact factor: 8.551

5.  The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.

Authors:  J W Young; L Koulova; S A Soergel; E A Clark; R M Steinman; B Dupont
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain.

Authors:  E Puré; K Inaba; M T Crowley; L Tardelli; M D Witmer-Pack; G Ruberti; G Fathman; R M Steinman
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

7.  Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells.

Authors:  H Stössel; F Koch; E Kämpgen; P Stöger; A Lenz; C Heufler; N Romani; G Schuler
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

8.  Accessory cell-T lymphocyte interactions. Antigen-dependent and -independent clustering.

Authors:  K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

9.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.

Authors:  C P Larsen; P J Morris; J M Austyn
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

10.  Isolation and characterization of human tonsil dendritic cells.

Authors:  D N Hart; J L McKenzie
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  23 in total

1.  Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.

Authors:  G Girolomoni; M T Valle; V Zacchi; M G Costa; A Giannetti; F Manca
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.

Authors:  A Blauvelt; H Asada; M W Saville; V Klaus-Kovtun; D J Altman; R Yarchoan; S I Katz
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  GM-CSF mRNA and protein in human skin-derived lymph.

Authors:  N Yawalkar; C U Brand; L R Braathen
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

4.  Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis.

Authors:  N Seo; Y Tokura; T Nishijima; H Hashizume; F Furukawa; M Takigawa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Dendritic cells and macrophages in the uveal tract of the normal mouse eye.

Authors:  P G McMenamin
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

6.  Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells.

Authors:  S L Newman; A Holly
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Tobacco smoke-induced immunologic changes may contribute to oral carcinogenesis.

Authors:  Michael Schierl; Daxesh Patel; Wanhong Ding; Amit Kochhar; Katayun Adhami; Xi Kathy Zhou; Andrew J Dannenberg; Richard D Granstein
Journal:  J Investig Med       Date:  2014-02       Impact factor: 2.895

8.  Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.

Authors:  M Saurwein-Teissl; K Zisterer; T L Schmitt; R Glück; S Cryz; B Grubeck-Loebenstein
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

9.  Functional studies of major histocompatibility class II-positive dendritic cells and resident tissue macrophages isolated from the rat iris.

Authors:  R J Steptoe; P G Holt; P G McMenamin
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

10.  Expression of human beta defensins (HBDs) 1, 2 and 3 in gingival crevicular fluid of patients affected by localized aggressive periodontitis.

Authors:  Mohamed Abdelmoniem Ebrahem
Journal:  Saudi Dent J       Date:  2013-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.